Intuitive Surgical, Inc. Stock

Equities

ISRG

US46120E6023

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX 11:37:00 2024-06-07 am EDT 5-day change 1st Jan Change
419.5 USD +0.31% Intraday chart for Intuitive Surgical, Inc. +4.06% +24.04%
Sales 2024 * 8.03B Sales 2025 * 9.32B Capitalization 148B
Net income 2024 * 1.97B Net income 2025 * 2.27B EV / Sales 2024 * 17.8 x
Net cash position 2024 * 5.19B Net cash position 2025 * 7.75B EV / Sales 2025 * 15.1 x
P/E ratio 2024 *
76.4 x
P/E ratio 2025 *
66 x
Employees 13,676
Yield 2024 *
-
Yield 2025 *
-
Free-Float 99.44%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.31%
1 week+4.06%
Current month+4.06%
1 month+7.67%
3 months+6.56%
6 months+34.31%
Current year+24.04%
More quotes
1 week
397.47
Extreme 397.47
420.55
1 month
379.67
Extreme 379.67
420.55
Current year
320.26
Extreme 320.26
420.55
1 year
254.85
Extreme 254.85
420.55
3 years
180.07
Extreme 180.07
420.55
5 years
120.17
Extreme 120.1667
420.55
10 years
41.10
Extreme 41.095
420.55
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 96-03-31
President 56 96-02-29
Director of Finance/CFO 52 13-03-31
Members of the board TitleAgeSince
Director/Board Member 65 17-03-31
Director/Board Member 66 07-10-18
Director/Board Member 71 10-03-31
More insiders
Date Price Change Volume
24-06-07 418.4 +0.06% 315 521
24-06-06 418.2 +0.22% 1,733,351
24-06-05 417.2 +2.61% 2,226,648
24-06-04 406.6 +0.68% 936,150
24-06-03 403.9 +0.43% 913,144

Delayed Quote Nasdaq, June 07, 2024 at 11:22 am EDT

More quotes
Intuitive Surgical, Inc. specializes in the design, manufacturing, and marketing of robotic surgical assistance video systems. The systems consist of a surgical console, arm, remote-controlled endoscope, and 3D visual immersion system. Net sales break down by activity as follows: - sale of instruments and accessories (60%): primarily wrist cuffs; - sale of robotic systems (23.6%): systems marketed under the da Vinci brand (1,370 units sold in 2023) and intended primarily for urological, cardio-thoracic, and gynecological surgeries; - installation and training services (16.4%). The United States accounts for 65.8% of net sales.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
418.2 USD
Average target price
423.6 USD
Spread / Average Target
+1.30%
Consensus